STOCK TITAN

RCUS shareholder (NASDAQ: RCUS) details 4,343-share Rule 144 sale plan

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A shareholder of RCUS, Alexander Azoy, plans to sell 4,343 shares of common stock through Morgan Stanley Smith Barney on or about 12/18/2025 on the NYSE, with an aggregate market value of $96,762.04, compared with 107,973,536 shares outstanding.

The shares to be sold were acquired from the issuer on 12/15/2025 as restricted stock units. The notice also lists recent Rule 10b5-1 sales in the past three months, including 1,900 shares sold on 11/26/2025 for $49,400 and 2,831 shares sold on 09/29/2025 for $36,803.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many RCUS shares are planned to be sold under this Form 144?

The notice states that 4,343 shares of RCUS common stock are planned to be sold, with an aggregate market value of $96,762.04.

When and where is the planned sale of RCUS shares expected to occur?

The planned sale of 4,343 RCUS shares is scheduled for approximately 12/18/2025 on the NYSE.

How were the RCUS shares to be sold under this Form 144 acquired?

The 4,343 RCUS shares were acquired from the issuer on 12/15/2025 as restricted stock units.

What recent RCUS share sales by Alexander Azoy are disclosed?

The disclosure lists 1,900 shares sold on 11/26/2025 for $49,400.00 and 2,831 shares sold on 09/29/2025 for $36,803.00 as 10b5-1 sales.

How many RCUS shares are shown as outstanding in this Form 144?

The securities information section shows 107,973,536 RCUS common shares outstanding.

Which broker is handling the planned RCUS share sale?

The planned sale will be executed through Morgan Stanley Smith Barney LLC Executive Financial Services at 1 New York Plaza, 8th Floor, New York, NY 10004.

What representation does the seller make about information on RCUS?

By signing the notice, the seller represents that they do not know any material adverse information about the issuer's operations that has not been publicly disclosed.
Arcus Bioscience

NYSE:RCUS

RCUS Rankings

RCUS Latest News

RCUS Latest SEC Filings

RCUS Stock Data

2.70B
84.75M
34.73%
67.52%
9.24%
Biotechnology
Pharmaceutical Preparations
Link
United States
HAYWARD